Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, v.95, n.1, p.99-101, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Treatment of infections caused by A. baumannii is becoming a challenge due to the ability to develop multidrug-resistance, virulence, and high mortality. We described the colistin resistance and virulence genes present in sixA. baumannii clinical isolates using WGS, expression by qPCR, and virulence in the Galleria mellonella model. The colistin-resistant isolates were assigned as ST233 and the colistin-susceptible isolates as ST236 and ST407. The colistin-resistant isolates contained mutations within PmrA/PmrB, and the pmrA showed up-regulation in all of them. Only one colistin-resistant isolate indicating virulence in G. mellonella. This particular isolate belonged to a different clone, and it was the only isolate that presented non-synonymous mutations in pmrB. Colistinresistance in A. baumannii isolates seems to be caused by up-regulation of pmrA gene. Only one isolate appeared to be virulent in the G. mellonella model. This finding indicating low virulence in isolates belonging to emerging clones circulating in our hospital.
Palavras-chave
Acinetobacter baumannii, Galleria mellonella, whole-sequencing, colistin-resistant, resistance, virulence
Referências
  1. Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09
  2. Arroyo LA, 2011, ANTIMICROB AGENTS CH, V55, P3743, DOI 10.1128/AAC.00256-11
  3. Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]
  4. Clinical and Laboratory Standard Institute, 2013, M100 CLSI
  5. Dias VC, 2016, J INFECT DEV COUNTR, V10, P544, DOI 10.3855/jidc.6640
  6. Goh HMS, 2013, APPL ENVIRON MICROB, V79, P6535, DOI 10.1128/AEM.01402-13
  7. Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
  8. Kavanagh Kevin, 2010, Fungal Biology Reviews, V24, P79, DOI 10.1016/j.fbr.2010.04.001
  9. Leite GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151270
  10. Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
  11. Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
  12. Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07
  13. Lopez-Rojas R, 2011, J INFECT DIS, V203, P545, DOI 10.1093/infdis/jiq086
  14. Park YK, 2011, INT J ANTIMICROB AG, V37, P525, DOI 10.1016/j.ijantimicag.2011.02.008
  15. Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87, DOI 10.1007/S10551-011-0963-1
  16. Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0
  17. Wand ME, 2015, J ANTIMICROB CHEMOTH, V70, P2209, DOI 10.1093/jac/dkv097
  18. Zarrilli R, 2016, VIRULENCE, V7, P367, DOI 10.1080/21505594.2016.1150405